NEW YORK (GenomeWeb News) – The US Army has selected Microchip Biotechnologies to participate in its inaugural Commercialization Pilot Program.
The firm has been developing a biothreat detection system through small business innovation research funding from the Army.
The Army’s new program is focused on identifying SBIR firms with Phase II projects that may “meet high-priority Army requirements,” the company said. However, it did not say how much funding is associated with its participation in the program.
Microchip Biotechnologies said that it is one of 25 firms selected for the program out of an applicant pool of 416 firms.